Drug recall · October 28, 2026
Telmisartan and Amlodipine recall
Why: Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India, NDC 0378-1075-93.
- Lots / codes
Lot # 3228113, 3228114, 3228115, Exp Date: Oct 31, 2026; Lot # 3228120, 3228121, Exp Date: Nov 30, 2026.
- Quantity
- 21,620 30-count bottles
- Company
- Viatris, Inc., Morgantown, WV
- Distribution
- Nationwide in the USA.
- Initiated
- October 1, 2026 · Voluntary: Firm initiated
- Classified
- October 16, 2026
- Reported
- October 28, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amlodipine / telmisartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.